# Sanemus

Sanemus is a Private Equity based in Munich, Germany.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Munich, Germany
- **Region:** Europe
- **Address:** Munich, Germany
- **Founded:** 2006
- **Assets under management:** Undisclosed
- **Website:** www.sanemus.com
- **LinkedIn:** https://linkedin.com/company/sanemus-ag

## Regulatory record

- **Reports private funds:** No

## About

SANEMUS AG investiert fokussiert in Unternehmens- und Vermögensbeteiligungen im deutschen Gesundheitsmarkt und bietet Dritten Strategic-, Financial- und Merger&Acquisition-Advisory an. Sie wurde 2006 von erfahrenen Persönlichkeiten aus dem Gesundheitswesen in München gegründet. Der Investitionsfokus liegt auf dem Life Science Bereich mit den Teilmärkten Pharmazeutische Industrie, Biotechnologie, Medizintechnik, Diagnostik und E-Health.

## Sectors

- Pharmaceuticals
- Biotech
- Medical Devices
- Diagnostics
- Digital Health

## People

- Michael Thiess — Partner and Board Member
- Sonja Hager — Member of Management

## Questions

### What does Sanemus actually own?

The firm website lists three active portfolio companies. ProPharm AG is a cooperative network of 75 independent German pharmacies that bundles purchasing, marketing, and mail-order services. Aureleon Diagnostics GmbH is developing multiplex diagnostic tests for cardiac and oncology applications. 52masterworks GmbH runs a crowd-investing marketplace for contemporary fine art.

### Who makes investment decisions at Sanemus?

Michael Thiess leads the investment process in his role as partner and board member. Sonja Hager, a Certified Private Equity Analyst, joined the management board in December 2023 and supports decision-making as the senior investment professional. The three-member supervisory board offers additional governance.

### Does Sanemus operate like a traditional venture firm?

No. The company identifies as a private equity firm but does not raise funds from external limited partners. It invests its own balance-sheet capital alongside its advisory business, which generates outside fee revenue from strategic and M&A consulting, blurring the line between a fund manager and a corporate-finance boutique.

### What investment stages does Sanemus target?

Altss research tags the firm as active across early-stage start-up, expansion, and growth phases. The portfolio reflects this range: ProPharm was a late-stage service-platform investment, while aureleon diagnostics represents a clinical-stage life-science play.

### Which healthcare sub-sectors does Sanemus focus on?

The firm explicitly names pharmaceuticals, biotechnology, medical technology, diagnostics, and e-health. Its pharmaceutical investments center on distribution and margin improvement rather than drug discovery, while the diagnostics exposure targets algorithmic multiplex biomarker analysis.

### How is the advisory business separated from the investment portfolio?

Both sit inside Sanemus AG. The firm publicly states it offers strategic, financial, and M&A advisory to third parties while managing its own direct investments. Fee income from advisory mandates replenishes the investment pool organically, which means the firm can deploy capital without marketing to external LPs.

## Related profiles

- [Saned Equity Partners](https://altss.com/profile/saned-equity-partners)
- [San Francisco Culinary Bartenders & Service Employees Pension Plan](https://altss.com/profile/san-francisco-culinary-bartenders-service-employees-pension-plan)

---

Last updated: 2026-08-11T15:08:04.536Z

Canonical page: https://altss.com/profile/sanemus

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology